CD4+ T-cell differentiation and function: Unifying glycolysis, fatty acid oxidation, polyamines NAD mitochondria - 05/07/21
, Tim Sparwasser, MD a, d, ⁎, ‡ 
Abstract |
The progression through different steps of T-cell development, activation, and effector function is tightly bound to specific cellular metabolic processes. Previous studies established that T-effector cells have a metabolic bias toward aerobic glycolysis, whereas naive and regulatory T cells mainly rely on oxidative phosphorylation. More recently, the field of immunometabolism has drifted away from the notion that mitochondrial metabolism holds little importance in T-cell activation and function. Of note, T cells possess metabolic promiscuity, which allows them to adapt their nutritional requirements according to the tissue environment. Altogether, the integration of these metabolic pathways culminates in the generation of not only energy but also intermediates, which can regulate epigenetic programs, leading to changes in T-cell fate. In this review, we discuss the recent literature on how glycolysis, amino acid catabolism, and fatty acid oxidation work together with the tricarboxylic acid cycle in the mitochondrion. We also emphasize the importance of the electron transport chain for T-cell immunity. We also discuss novel findings highlighting the role of key enzymes, accessory pathways, and posttranslational protein modifications that distinctively regulate T-cell function and might represent prominent candidates for therapeutic purposes.
Le texte complet de cet article est disponible en PDF.Key words : T cell, CD4, metabolism, immunometabolism, mitochondria, antibiotics, polyamine, fatty acid oxidation, arginine
Abbreviations used : AMPK, BATF, C, CD4-TFAMΔ, CPT, EAE, ETC, FA, FAO, FoxP3-TFAMΔ, Gpi1, LC, LDH, LDHA, mtDNA, ND6, ND6mut, OXPHOS, PDH, PPP, RISP KO, SFB, TCA, Teff, Tfam, Tfh, TME, Treg, WT
Plan
| This work was supported by grants from the Deutsche Forschungsgemeinschaft (grant nos. CRC156 and CRC1292). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
|
| Terms in boldface and italics are detailed in the glossary on page 17. |
Vol 148 - N° 1
P. 16-32 - juillet 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
